Safety and tolerance of trimetrexate: results of a phase II multicenter study in patients with metastatic cancer refractory to conventional therapy or for which no conventional therapy exists

Semin Oncol. 1988 Apr;15(2 Suppl 2):10-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Drug Evaluation
  • Drug Resistance
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasms / drug therapy*
  • Quinazolines / adverse effects*
  • Trimetrexate

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Trimetrexate